Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Fuji
UBS
Fish and Richardson
Johnson and Johnson
Covington
Teva
Express Scripts
McKinsey

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018150

« Back to Dashboard

NDA 018150 describes THALLOUS CHLORIDE TL 201, which is a drug marketed by Bracco, Ge Healthcare, Lantheus Medcl, Mallinkrodt Nuclear, and Trace Life, and is included in six NDAs. It is available from three suppliers. Additional details are available on the THALLOUS CHLORIDE TL 201 profile page.

The generic ingredient in THALLOUS CHLORIDE TL 201 is thallous chloride tl-201. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the thallous chloride tl-201 profile page.
Summary for 018150
Tradename:THALLOUS CHLORIDE TL 201
Applicant:Mallinkrodt Nuclear
Ingredient:thallous chloride tl-201
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 018150
Mechanism of ActionRadiopharmaceutical Activity
Suppliers and Packaging for NDA: 018150
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
THALLOUS CHLORIDE TL 201 thallous chloride tl-201 INJECTABLE;INJECTION 018150 NDA MALLINCKRODT NUCLEAR MEDICINE LLC 69945-120 N 69945-120-28
THALLOUS CHLORIDE TL 201 thallous chloride tl-201 INJECTABLE;INJECTION 018150 NDA MALLINCKRODT NUCLEAR MEDICINE LLC 69945-120 N 69945-120-56

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1mCi/ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Chubb
Federal Trade Commission
Dow
Fuji
Johnson and Johnson
Medtronic
Colorcon
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.